A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease

NCT00552344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

BIOLOGICAL: Cimzia

Sponsor

UCB BIOSCIENCES GmbH

Collaborators

[object Object]